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Abstract
Background: Inflammatory adhesions result from an inflammatory response of the peritoneum during an intra-abdominal inflammatory process secondary 
to thermal or mechanical injury, infection, radiation, ischemia, dissection, abrasion or foreign body reaction. Adhesions produce consequences such as: 
infertility, intestinal obstruction, and pelvic-abdominal pain. The objective of this study is to evaluate the effects of Meloxicam, a selective cyclooxygenase-2 
inhibitor, on the formation of postoperative peritoneal adhesions in an experimental animal model. Methods: Twenty female Wistar rats were submitted 
to laparotomy. Postoperative peritoneal adhesions were induced by scorching the serous surface of the colon. The animals were randomly divided into 
two experimental groups: one group received Meloxicam intramuscularly for 7 days, and the other served as a control group. They were sacrificed and 
evaluated at 15 days. Results: In the animals given Meloxicam, it was observed that a decrease in number (p = 0.018), severity (p = 0.004), extension 
(p = 0.011), density (p = 0.023), degree of inflammation (p = 0.002), vascular proliferation (p = 0.004) and fibrosis (p = 0.029) of adhesions, compared to 
the control group. Conclusion: In conclusion, this study demonstrated that the administration of Meloxicam intramuscularly significantly decreases the 
formation of postoperative peritoneal adhesions and, therefore, may be useful in their prevention. The effects of Meloxicam could not only be due to its 
anti-inflammatory action, but also to its effects on the expression of the Vascular Endothelial Growth Factor.
Keywords: Cyclooxygenase 2 Inhibitors; Experimental Animal Models; General Surgery; Non-Steroidal Anti-Inflammatory Agents; Tissue 
Adhesions.
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Introduction
Peritoneal adhesions are pathological junctions of connective 
tissue formed between organs and tissues, and frequently be-
tween the omentum, intestines and abdominal wall. The etiolo-
gy may be congenital or acquired. The acquired adhesions are 
classified postoperatively or postinflammatory. Inflammatory 
adhesions result from an inflammatory response of the peri-
toneum during an intra-abdominal inflammatory process, such 
as appendicitis and pelvic inflammatory disease. Post-surgical 
adhesions develop when a tissue is injured by surgical mani-
pulation. 1, 2
In a prospective study, 93% of patients with a previous lapa-
rotomy had peritoneal adhesions, and the incidence of read-
missions directly related to adhesions varies from 5% to 20%.3,4 
Each year, 400,000 adhesiolysis procedures are performed in 
the United States, with a cost in the health system of close to 
$ 2 trillion in hospitalizations and surgeries. 5
Adhesions are the result of tissue trauma that may be the 
consequence of thermal or mechanical injury, infection, radia-
tion, ischemia, dissection, abrasion, or foreign body reaction.6 
However, the most important and potential consequences re-
sulting from the formation of peritoneal adhesions are: inferti-
lity, intestinal obstruction, and pelvic-abdominal pain. They can 
affect fertility by distorting the attached anatomy and interfere 
with the transport of the gamete and embryo. 6
The most serious of the complications caused by adhesions is 
small bowel obstruction.7 Adhesions account for 56% of posto-
perative intestinal obstructions.8 This surgical emergency has 
a mortality rate of 3-10% for simple obstruction, and up to 30% 
when the intestine is necrotic or perforated. In one study, it 
was evidenced that of 2000 patients submitted to laparotomy 
1-2% developed obstruction secondary to peritoneal adhesions 
in the same year of surgery. The incidence of intestinal obstruc-
tion secondary to adhesion formation is 1-10% in 4-6 years af-
ter appendectomy, 6% in 5 years after cholecystectomy, 9-25% 
in 2-10 years following intestinal surgery, and 17-25 % in 5-10 
years following proctocolectomy.8
However, peritoneal adhesions are not a new problem, sur-
geons have studied different barrier/pharmacological agents to 
prevent the formation of adhesions.9 In this way, different syn-
thetic barrier methods have been used for its prevention.10.11 
Among the pharmacological agents studied are: allopurinol, 
thymoquinone, phospholipids, spironolacton e, captopril, he-
parin has been studied.1, 6, 12-14  Also a variety of steroids and 
anti-inflammatory agents have been studied, including aspirin, 
dexamethasone, methylprednisolone, estrogen, progesterone 
and budesonide.15 Likewise, the use of hemostatic agents, and 
the effects of vitamin E and amniotic membrane on the forma-
tion of adhesions have been researched.16, 17 However, none of 
these pharmacological agents and barrier methods have de-
monstrated clinically relevant results in reducing chronic pain, 
decreased infertility, and rate of reoperation.18
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Meloxicam, is a non-steroidal anti-inflammatory categorized as 
a selective COX-2 inhibitor. It is commonly used in the treat-
ment of acute and chronic pain and inflammation.19 The ob-
jective of this study is to evaluate the anti-inflammatory effects 
of Meloxicam in the formation of postoperative peritoneal ad-
hesions in an experimental animal model. Therefore, in the 
present study we proposed the use of an experimental model 
of adhesion formation by serosal abrasion of the colon, ha-
ving a control group without drug administration and a group 
to which Meloxicam was given intramuscularly. In light of the 
above considerations and by its mechanism of action, it is 
proposed as an alternative hypothesis that Meloxicam inhibits 
the formation of postoperative peritoneal adhesions; and as a 
null hypothesis, that Meloxicam does not inhibit the formation 
of adhesions.
Materials and Methods
An experimental study was carried out in an animal model, in 
which 20 female rats, Wistar strain, between 250 and 300 g in 
weight were used. Two experimental rats were kept per cage, 
with food and water to free demand. The bed of each cage was 
changed twice a week. They were under cycles of 12 hours light 
and 12 hours darkness and a temperature in the experimental 
laboratory of 22ºC ± 2ºC. 
All procedures of the research protocol were carried out strict-
ly taking into account the principles for the care and use of 
laboratory animals, according to the bioethics criteria for the 
experimentation of the Venezuelan Association for the Science 
of Laboratory Animals.20
Before the operation, the experimental animals were randomly 
distributed into two groups consisting of 10 animals each: a 
control group and a study group.
In each experimental rat, we proceeded to perform a surgical 
procedure with the goal to induce the adhesion formation pro-
cess. Each subject was previously anesthetized by administra-
tion of 100 mg/kg Ketamine (Keiran®) and 10 mg/kg Xylazine 
(Rompun®), both intramuscularly.
The abdominal skin was disinfected with Povidone Iodine so-
lution (BETADINE®), prior to the procedure. After, a vertical 
midline incision measuring 3 cm in length was made, the lar-
ge intestine of the rat was exposed and the induction of the 
Figure 1. Some of the Procedures Performed During the Adhesion-Forming Surgery and the Immediate Postoperative Period of 
the Rat. A. Exposure of the large intestine of the rat B. The skin and subcutaneous cellular tissue were closed with 4-0 nylon. C. 
Postoperative immediately, the experimental animal is in an incubator (medix®, model PC-305) adjusted to 32ºC, enabled for its 
recovery.
process of formation of peritoneal adhesions was carried out 
by a technique already described, which consisted of injuring 
the serosa of the large intestine by vigorous rubbing with dry 
gauze (Figure 1A). The rubbing was maintained until the appea-
rance of hemorrhagic points. This procedure was performed in 
5 segments corresponding to the cecum, 1 ascending colon 
segment, 1 transverse colon segment, 1 descending colon seg-
ment and sigmoid segment. Each segment was 1 cm in length.
The abdominal wall was closed, suturing the aponeurosis and 
rectus abdominis muscle with Polyglactin 910 (Vycril®) 4-0; 
skin and subcutaneous cellular tissue with 4-0 nylon (Figure 
1B). At the end of the surgical procedure, each experimental 
animal was placed in an incubator (Medix®, model PC-305) 
set at 32ºC, where they lasted for 4 hours with the finality to 
achieve recovery (Figure 1C).
In terms of treatment, the control group had no therapy 
applied. The study group, was administered Meloxicam (Mo-
bic®, Boehringer Ingelheim) intramuscularly, at a dose of 0.20 
mg/kg/day, for 7 days, starting right after the surgery.
All experimental rats were sacrificed at day 15 postoperative, 
under the effects of anesthesia already described. 1 mL of 7.5% 
Potassium Chloride was administered via intracardiac injection, 
via a thoracotomy to achieve exposure of the heart.
An abdominal "U" incision was made by lifting the abdominal 
wall of the experimental rat with the objective to evaluate the 
adhesions formed, registering their presence or absence, for-
mation in unmanipulated organs, and whether there were an-
terior or posterior abdominal wall attachments. Likewise, each 
of the adhesions presented by the experimental animals of 
each group was counted.
The degree of severity, dissection and extension were evalua-
ted according to the classification of Diamond.21 According to 
the severity, it was considered: Grade 0, without adhesions; 
Grade 1, thin and avascular adhesions were evident; Grade 2, 
vascularized and dense adhesions were observed; Grade 3, ad-
hesions were firm and cohesive. As for its extension: Grade 0, 
without adhesions; Grade 1, less than 25%; Grade 2, between 
26% and 50%, Grade 3, more than 50% of surface. The density 
was evaluated by the following: Grade 0, without adhesions; 
Grade 1, the adhesions were released spontaneously upon se-
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paration of the flap; Grade 2, mild to moderate traction was 
required to separate the adhesions; Grade 3, those that meri-
ted adhesiolysis with scissors. Adhesion tissue samples were 
dehydrated, placed in paraffin, and then 3 micron cuts were 
made with a rotating microtome (MICROM®). The sections 
were stained with Haematoxylin and Eosin (H/E) and Masson’s 
Trichrome stain. The surgical pieces were analyzed by a blind 
observer to the procedure, in the laboratory of Histopathology 
of the Hospital Complex University Ruíz and Paez, Ciudad Bo-
lívar, Venezuela.
The histological characteristics of the adhesions were determi-
ned according to the histological classification of Kanbour-Sha-
kir, which evaluates three aspects: fibrosis, inflammation and 
vascular proliferation. Firstly, fibrosis is measured by the per-
centage of occupation of fibroblasts in a dry field of obser-
vation (mild <33%, moderate > 33% and < 66%, severe > 66%, 
and no fibroblast proliferation). Secondly, inflammation invol-
ves observing the presence of inflammatory cells and classi-
fying it as mild (infiltrating with occasional giant cells, lym-
phocytes and plasma cells), moderate (giant cells, eosinophils 
and neutrophils) and severe (abundant inflammatory cells and 
microabscesses) or absence of an inflammatory component. 
Lastly, vascular proliferation, defined as the number of blood 
vessels present per area in 40x magnification or high powered 
field, classified as mild (blood vessels in less than 33% of the 
field extension), moderate (in more than 33% and less than 
66% of the area) and severe (> 66%) or without blood vessels.22
Statistical analysis was performed using the SPSS software 
(version 23; Statistical Package for the Social Sciences, SPSS 
Inc, Chicago, IL). The normality of the variables was evaluated 
by the Shapiro-Wilk test. For the comparison of the means of 
each group: the quantitative variables with a normal distribu-
tion were assessed with the Student’s t-test for independent 
samples; variables not fulfilling a normal distribution were eva-
luated by the Mann-Whitney U-test; and the qualitative varia-
bles were evaluated with the Chi-square test. The confidence 
interval was set at 95% and the differences were considered 
statistically significant when the p-value was ≤0.05.
Results
All experimental animals completed the study. No congenital ad-
hesions were evident in any of the rats in the first surgical inter-
vention. After the surgical procedure, there were no complications 
such as wound infections, peritonitis or intestinal obstruction. 
Regarding the presence of adhesions formed after the surgical in-
Figure 2. Degree of severity, density and extent of peritoneal adhesions. *Statistical significance compared with control group.
Figure 3. Degrees of Severity of Peritoneal Adhesions Evidenced During Macroscopic Assessment. A. Rat of the study group (Me-
loxicam), which demonstrates a loose adhesion that could be released exclusively with traction. B. Strong and cohesive peritoneal 
adhesions between several thin intestinal loops, with a greater than 50% extension of the abdominal cavity, which required adhe-
siolysis with scissors for their release. C. Adhesions of the small intestine to the anterior abdominal wall (in the control group rat) 
involving more than 50% of the abdominal cavity with a high degree of severity and impossibility of release, only by adhesiolysis.
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Figure 4. Degrees of fibrosis, inflammation and vascular proliferation in postoperative peritoneal adhesions. *Statistical significan-
ce compared with control group.
duction procedure, 18 of 20 research animals had at least one 
adhesion. Peritoneal adhesions were formed in all rats (10 of 10 
animals) belonging to the control group, while in the rats belon-
ging to the study group (with administration of Meloxicam) the 
adhesions were evident in 8 of 10 experimental animals.
It was observed that the group of animals that were administered 
meloxicam after the surgical procedure two animals had only a 
single adhesion. The total adhesions per experimental group were: 
32 in the group treated with meloxicam and 183 in the control 
group. The mean number of adhesions per group was 18.3 for 
the control group and 3.2 for the study group (Table 1). These 
differences were statistically significant (control vs. study group, 
p = 0.018).
7 of 10 animals in the control group presented with adhesions 
in unmanipulated organs during the surgical procedure, whereas 
in the study group none of the experimental animals presented 
with adhesions in unmanipulated organs. There was a statistically 
significant difference between the two groups, p = 0.001 (Table 2). 
The presence of adhesions with anterior or posterior abdominal 
wall attachment occurred in 4 of 10 animals belonging to the con-
trol group. However, this characteristic was not evidenced in the 
group of animals who were administered meloxicam. There was a 
statistical difference denoting p = 0.025, in relation to adhesions to 
the anterior and posterior abdominal wall (Tables 3 & 4).
Regarding the assessment of adhesions, statistically significant 
differences were evidenced, according to their severity, extension 
and density (ease for dissection), with corresponding p values: p = 
0.004, p = 0.011 and p = 0.023, respectively (Figures 2 & 3).
In the histopathological study (Figures 4 & 5), the development 
of different degrees of fibrosis was evidenced, depending on the 
treatment group. Animals treated with Meloxicam had a lower de-
gree of fibrosis, and this difference was statistically significant 
when compared to the control group (p = 0.029).
Likewise, a statistically significant difference was observed when 
the inflammation and vascular proliferation were evaluated in 
both experimental groups, denoting p values of p = 0.002 and p = 
0.004, respectively.
Discussion
The objective of this study was to evaluate the effects of Me-
loxicam on the formation of postoperative peritoneal adhesions 
in an experimental animal model, which consisted of the serous 
abrasion of the rat colon. The results of the macroscopic evalua-
tion showed that the animals belonging to the group administered 
Meloxicam developed fewer adhesions and had no adhesions in 
unmanipulated organs. As for the histological evaluation, it was 
evidenced that the Meloxicam group under study developed a 
lower degree of fibrosis, inflammation and vascular proliferation. 
In contrast, after peritoneal trauma by serosal abrasion of the 
colon, all rats in the control group developed peritoneal adhesions 
and greater degrees of severity than the rats given Meloxicam.
The trauma to the peritoneum triggers a cascade of events that 
begins with the disruption of mast cells, which release vasoactive 
substances such as histamine that increase vascular permeabili-
ty.6 In addition, extravasation of a fibrinogen rich fluid occurs from 
the injured surfaces. Simultaneously, an inflammatory response 
occurs, with migration of inflammatory cells, release of cytokines 
and activation of the coagulation cascade. Activation of the coa-
gulation system results in the formation of thrombin, which is ne-
cessary for the conversion of fibrinogen to fibrin. Since fibrinolysis 
is the key determinant in the formation of adhesions. If this does 
not occur within 5 to 7 days following peritoneal injury, the fibrin 
matrix persists and is gradually further organized with collagen 
secreting fibroblasts.4
Fibroblasts and myofibroblasts secrete massive amounts of extra-
cellular matrix molecules including fibronectin, hyaluronic acid, 
glycosaminoglycans, and proteoglycans. This process establishes 
a bridge between tissues within a few weeks. Further evidence 
includes vascularization and deposits of collagen in this adhesion 
bridge formed between the two tissues.9
The formation of peritoneal adhesions results from a complex cas-
cade regulated by different cellular and humoral factors. Among 
the cellular factors are the mesothelial cells, different types of 
inflammatory cells and fibroblasts. The relationship of these cells 
and their structural organization is regulated by cytokines, growth 
factors and signaling molecules. It is widely accepted that in local 
tissue injury, ischemia, the resulting inflammatory response, and 
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Figure 5. Images Obtained from the Histopathological Evaluation of Experimental Animals. A. Histopathological image representing 
a sample of tissue with adhesions in which large areas of loose connective tissue and inflammatory infiltrate (star), with presence 
of giant cells (green arrow), fibroblast (blue arrow) and mild vascular proliferation (black arrow) were observed (Hematoxylin-eo-
sin stain; original magnification X40). B. Sample of tissue in which the intestinal mucosa (star), the muscularis externa (blue 
arrow), areas of fibrosis and presence of infiltration of inflammatory cells (black arrow) were observed (Hematoxylin-eosin stain; 
original magnification X10) C. Sample of tissue in which were evidenced: the intestinal mucosa (star), the muscularis externa 
(blue arrow) and areas of loose connective tissue (black arrow). (Hematoxylin-eosin stain; original magnification X5). D. Histo-
logical image belonging to rat, in which no adhesions were observed in the macroscopic evaluation. Highlighted areas include 
the intestinal mucosa (star), the submucosa (black arrow) and the muscularis externa (blue arrow). (Hematoxylin-eosin stain; 
original magnification X5).  E. Histological image in which the intestinal mucosa (black star), the submucosa (blue star) with blood 
vessels (black arrow), the muscularis externa (blue arrow) and the serosa (green arrow), without inflammatory process, vascular 
proliferation and fibrosis. (Hematoxylin-eosin stain; original magnification X10).
the promotion of procoagulatory processes such as antifibrinolytic 
reactions are essential for the formation of peritoneal adhesions.23
Peritoneal damage causes an inflammatory response, in which in-
flammatory cells release cytokines, such as Tumor Necrosis Factor 
alpha (TNF-alpha), interleukin 1 and 6. These cytokines induce 
the release of plasminogen activator inhibitor-1 and 2 (PAI-1 and 
PAI-2) of mesothelial cells, which results in a reduction in Plasmi-
nogen activator (Pas) activity. In this way, PAI inhibits fibrinolysis, 
and fibrin deposits are infiltrated by granulocytes, monocytes and 
fibroblasts, followed by capillary growth, collagen deposits and 
adhesion formation.24
Likewise, an increase in COX-2 expression has been shown in 
response to hypoxia in normal peritoneum fibroblasts. However, 
COX-1 expression remains unchanged in adhesions and fibroblasts 
under conditions of normoxia and hypoxia. It is hypothesized that 
hypoxia leads to fibroblasts of the normal peritoneum to acqui-
re a phenotype of adhesions as a manifestation of the marked 
increase in the expression of COX-2. 25 Hypoxia induces normal 
peritoneal fibroblasts to produce high levels of PGE-2 and COX-2, 
an effect that can be prevented by inhibition of COX-2. Therefore, 
it is considered that COX-2 and its inhibitor may play a role in the 
postoperative regulation of tissue repair and the development of 
adhesions.26, 27
VEGF is an angiogenic cytokine that participates in the adhesion 
formation process through the formation of new vessels. It is im-
plicated in early inflammatory responses, tissue repair and remo-
deling through fibroblast function. It is also important to facilitate 
fibrin rich matrix deposition, necessary for cell migration and pro-
liferation.28, 29
Also, it has been suggested that laparotomy can stimulate the for-
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mation of adhesions through a cellular process dependent on mast 
cells, an inflammatory process that is independent of immediate 
degranulation. Mast cells are probably not responsible for all loca-
lly released VEGF, because this cell produces cytokines that induce 
the influx of other inflammatory cells that could produce VEGF at 
the site of the lesion.28, 29
It has been shown that dexamethasone, a steroidal anti-inflam-
matory, in combination with sodium carboxymethylcellulose can 
prevent the formation of adhesions in a rat adhesion-forming mo-
del, inhibiting the migration of inflammatory cells, further decrea-
sing the proliferation of fibroblasts.30
Likewise, the use of non-steroidal anti-inflammatory drugs, such 
as Diclofenac Sodium, has been effective in decreasing adhesion 
formation in a model of anti-mesenteric border lesion in the rat co-
lon. In this same study, there was a decrease in the development 
of edema, hyperemia, inflammation and fibrosis.31
Similarly, inhibition of COX-2 by the administration of parecoxib, 
celecoxib, rofecoxib and nimesulide has been shown to decrease 
adhesion formation in animal models.32,33,34,35 Guvenal et al. asso-
ciated the effects of nimesulide in its study to its anti-prostaglan-
din activity and the reduction of the production of anti-angiogenic 
cytokines.34
However, in a study by Keskin et al., where Meloxicam and Dexke-
toprofen were evaluated in a rat uterine horn surgical model, it 
was shown that Meloxicam decreased the development of inflam-
mation.  However, despite a decrease in vascular proliferation and 
collagen formation, there was no significant decrease in adhesion 
formation.36 In contrast, in the present study Meloxicam was 
shown to decrease the formation of adhesions, the development 
of fibrosis, vascular proliferation and inflammation. This may be 
due to the fact that different techniques and experimental models 
were used in both studies. In addition, in the same study, Me-
loxicam was administered 2 days before surgery and 5 days after 
surgery, whereas in this study meloxicam was given for 7 days 
after the surgical procedure.
In an experimental model of periodontitis in rats, it was shown 
that after 14 days of treatment with Meloxicam, there was a de-
crease in the expression of VEGF expression.37 Similarly, it has 
been shown that Meloxicam decreases VEGF levels in tumor tis-
sues from animal experimental models.38 In a model of ovarian 
hyperstimulation syndrome in rats, the results suggest that Me-
loxicam affects the expression of VEGF in the ovary.39
In addition to the inhibition of the inflammatory process involved 
in the formation of adhesions in the Meloxicam group, there was 
also a significant decrease in the development of vascular proli-
feration. The mechanism is most likely due to a decrease in the 
production of VEGF by the cells involved in the process of adhesio-
nogenesis, such as mast cells.
Some limitations were evident in our study. The pathophysiologi-
cal process of peritoneal scarring was one of the limitations, be-
cause the mechanisms of adhesion formation in human have not 
been studied in great detail to warrant a direct comparison to the 
effects of meloxicam on adhesion formation in rats. The adverse 
and side effects of Meloxicam was also not examined in the study 
at the dose (0.20 mg/kg/day) and duration of treatment (7 days) 
used in the study. Despite the limitations of the study, meloxicam 
was shown to decrease the formation of postoperative peritoneal 
adhesions in the experimental model used.
In conclusion, Meloxicam, proved to be effective in the prevention 
of post-surgical peritoneal adhesions induced in the animal model 
used. It is a promising finding, based on the pathophysiological 
knowledge of inflammation, peritoneal healing and the involve-
ment of VEGF in the formation of peritoneal adhesions. Therefore, 
it is proposed to continue the research of this drug in other mo-
dels of experimentation, while performing the quantification of 
inflammatory markers, cytokines in plasma and peritoneal fluid. 
The final objective of future studies will be to understand the 
effects, positive or negative, of Meloxicam in the formation of ad-
hesions.
Characteristic Control (n=10) Meloxicam (n=10) P-value
Peritoneal adhesions, mean (SD) 18.30 (16.45) 3.20 (2.15) 0.018
Peritoneal adhesions formed in non-manipula-
ted organs*
0.003
    Yes, n (%) 7 (100) 0 (0) 0.003
    No, n (%) 3 (23.08) 10 (76.92) 0.003
Peritoneal adhesions formed attached to 
anterior abdominal wall*
0.087
    Yes, n (%) 4 (100) 0 (0) 0.087
    No, n (%) 6 (37.50) 10 (62.50) 0.087
Peritoneal adhesions formed attached to posterior 
abdominal wall*
0.087
    Yes, n (%) 4 (100) 0 (0) 0.087
    No, n (%) 6 (37.50) 10 (62.50) 0.087
Table 1. Clinical outcomes when comparing the interventions.
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